Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bilbao

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 17, 2008
High-dose-rate intensity modulated brachytherapy with external-beam radiotherapy improves local and biochemical control in patients with high-risk prostate cancerP J Prada, H González, J Fernández, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1995
The addition of interleukin-2 to cyclophosphamide therapy can facilitate tumor growth of B16 melanomaT Palomares, P Bilbao, A Alonso-Varona, et al.
Revista Espanola De Enfermedades Digestivas|December 1, 1993
[Protein-calorie malnutrition and degree of hepatic failure in chronic hepatopathy]S Pinedo, D Solano, F M de la Villa, et al.
Clinical & Experimental Metastasis|May 1, 1997
Interleukin-2 increases intracellular glutathione levels and reverses the growth inhibiting effects of cyclophosphamide on B16 melanoma cellsT Palomares, A Alonso-Varona, A Alvarez, et al.
Chemotherapy|October 29, 2000
Tunicamycin treatment reduces intracellular glutathione levels: effect on the metastatic potential of the rhabdomyosarcoma cell line S4MHY Calle, T Palomares, B Castro, et al.
Bulletin Du Cancer|January 1, 1996
Tumor-host interaction in non-random metastatic pattern distributionA Alonso-Varona, T Palomares, P Bilbao, et al.
Melanoma Research|May 10, 2000
Effects of L-2-oxothiazolidine-4-carboxylate on the cytotoxic activity and toxicity of cyclophosphamide in mice bearing B16F10 melanoma liver metastasesM del Olmo, A Alonso-Varona, B Castro, et al.
Melanoma Research|February 6, 2002
L-2-Oxothiazolidine-4-carboxylate reverses the tumour growth-promoting effect of interleukin-2 and improves the anti-tumour efficacy of biochemotherapy in mice bearing B16 melanoma liver metastasesP Bilbao, M del Olmo, A Alonso-Varona, et al.
Melanoma Research|August 28, 1999
In vitro and in vivo comparison between the effects of treatment with adenosine triphosphate and treatment with buthionine sulfoximine on chemosensitization and tumour growth of B16 melanomaT Palomares, P Bilbao, M del Olmo, et al.
Brachytherapy|December 7, 2016
Transperineal biopsies of MRI-detected aggressive index lesions in low- and intermediate-risk prostate cancer patients: Implications for treatment decisionA Gomez-Iturriaga, F Casquero, J I Lopez, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 17, 2008
High-dose-rate intensity modulated brachytherapy with external-beam radiotherapy improves local and biochemical control in patients with high-risk prostate cancerP J Prada, H González, J Fernández, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1995
The addition of interleukin-2 to cyclophosphamide therapy can facilitate tumor growth of B16 melanomaT Palomares, P Bilbao, A Alonso-Varona, et al.
Revista Espanola De Enfermedades Digestivas|December 1, 1993
[Protein-calorie malnutrition and degree of hepatic failure in chronic hepatopathy]S Pinedo, D Solano, F M de la Villa, et al.
Clinical & Experimental Metastasis|May 1, 1997
Interleukin-2 increases intracellular glutathione levels and reverses the growth inhibiting effects of cyclophosphamide on B16 melanoma cellsT Palomares, A Alonso-Varona, A Alvarez, et al.
Chemotherapy|October 29, 2000
Tunicamycin treatment reduces intracellular glutathione levels: effect on the metastatic potential of the rhabdomyosarcoma cell line S4MHY Calle, T Palomares, B Castro, et al.
Bulletin Du Cancer|January 1, 1996
Tumor-host interaction in non-random metastatic pattern distributionA Alonso-Varona, T Palomares, P Bilbao, et al.
Melanoma Research|May 10, 2000
Effects of L-2-oxothiazolidine-4-carboxylate on the cytotoxic activity and toxicity of cyclophosphamide in mice bearing B16F10 melanoma liver metastasesM del Olmo, A Alonso-Varona, B Castro, et al.
Melanoma Research|February 6, 2002
L-2-Oxothiazolidine-4-carboxylate reverses the tumour growth-promoting effect of interleukin-2 and improves the anti-tumour efficacy of biochemotherapy in mice bearing B16 melanoma liver metastasesP Bilbao, M del Olmo, A Alonso-Varona, et al.
Melanoma Research|August 28, 1999
In vitro and in vivo comparison between the effects of treatment with adenosine triphosphate and treatment with buthionine sulfoximine on chemosensitization and tumour growth of B16 melanomaT Palomares, P Bilbao, M del Olmo, et al.
Brachytherapy|December 7, 2016
Transperineal biopsies of MRI-detected aggressive index lesions in low- and intermediate-risk prostate cancer patients: Implications for treatment decisionA Gomez-Iturriaga, F Casquero, J I Lopez, et al.
Pageof 3